Safety and pharmacokinetics of atogepant in migraine
Key messages
- Once-daily oral atogepant 170 mg for the prevention of migraine was safe and generally well-tolerated over a 28-day period.
- Atogepant is rapidly absorbed and has an estimated half-life of ~10 hours.
- The potential risk of liver injury from multiple doses of atogepant appears to be relatively low.